- Services
- Team
- Patient Education
- Diagnosing MS
- Understanding Some Basics About MS
- Relapsing Remitting MS
- Secondary Progressive MS
- Primary Progressive MS
- Preparing for Your New Patient Visit
- Preparing for a Spinal Tap
- Injection & Medication Counseling
- Relapse vs. Pseudorelapse
- Neuromyelitis Optics vs. Multiple Sclerosis
- Resources
- FAQ
- Research
- News
- Contact
- Leave a Review
FDA Approves Lemtrada
11/17/14 - The FDA has approved Lemtrada (Alemtuzumab) for the treatment of RRMS. Lemtrada has been available to treat MS in Europe and Canada and has also been used in the United States to treat leukemia. Lemtrada will likely be reserved for patients with very aggressive forms of relapsing MS, as there are a number of safety considerations with this medication.
News Date :
Monday, November 17, 2014 - 20:24
IMSMP
Because you deserve only the best in MS healthcare. Experience the difference.
News & Events
Newsletter Sign Up
Join our mailing list today! Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.
* We don’t share your information with anyone.